Universal Health International Group Holding Limited provided earnings guidance for the year ended 30 June 2020. It is expected that the Group would record a loss of not less than RMB 490 million (equivalent to approximately HKD 536 million) for the year ended 30 June 2020 ("2019/20"). Details of which will be disclosed in the results announcement to be published in late September 2020. The Board considers that the expected significant increase in loss recorded for 2019/20 as compared to the year ended 30 June 2019 ("2018/19") was mainly attributable to the following factors: (i) Significant decrease in revenue resulting from, including, the economic downturn; the weakened purchasing power of the people living in the Northeast of the People's Republic of China; and the weakened consumer sentiment attributable to the outbreak of the novel coronavirus disease 2019 (COVID-19); (ii) Increase in marketing and administrative expenses of products with exclusive distribution rights during 2019/20; and (iii) The Group has made an analysis on the impact of the macro and industrial economic environment and performed an impairment assessment on goodwill and other related non- current assets. Basing on the signs of impairment, it is expected to make an impairment provision for goodwill and other related non-current assets. Despite the expected significant increase in loss for 2019/20 as compared to 2018/19, the Group strives to strengthen its internet sales and marketing and promotion efforts to mitigate the adverse effects of the external environment.